Association of the Reduced Function Met420del Polymorphism of SLC22A1 with Metformin-Induced Gastrointestinal ...
Introduction Metformin is indicated as a first-line glucose lowering agent for patients with type 2 diabetes mellitus (T2DM),1 though it has been frequently associated with gastrointestinal symptoms than most other oral glucose lowering agents.2,3 Moreover …